|
|
bevacizumab A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine. Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms: | | Anti-VEGF Anti-VEGF Humanized Monoclonal Antibody anti-VEGF monoclonal antibody Anti-VEGF RhuMAb Recombinant Humanized Anti-VEGF Monoclonal Antibody Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor rhuMAb VEGF | | | US brand name: | | Avastin | | |
|
|